Sentry Investments Corp. increased its position in McKesson Corporation (NYSE:MCK) by 12.8% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 928,230 shares of the company’s stock after buying an additional 105,400 shares during the period. McKesson Corporation makes up about 1.0% of Sentry Investments Corp.’s investment portfolio, making the stock its 21st largest position. Sentry Investments Corp. owned 0.44% of McKesson Corporation worth $137,619,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in MCK. Orrstown Financial Services Inc. boosted its stake in McKesson Corporation by 16.3% in the first quarter. Orrstown Financial Services Inc. now owns 715 shares of the company’s stock valued at $106,000 after buying an additional 100 shares in the last quarter. WFG Advisors LP boosted its position in shares of McKesson Corporation by 123.5% in the first quarter. WFG Advisors LP now owns 818 shares of the company’s stock valued at $121,000 after buying an additional 452 shares during the period. Welch Group LLC boosted its position in shares of McKesson Corporation by 22.6% in the first quarter. Welch Group LLC now owns 948 shares of the company’s stock valued at $141,000 after buying an additional 175 shares during the period. Tompkins Financial Corp boosted its position in shares of McKesson Corporation by 8.8% in the first quarter. Tompkins Financial Corp now owns 962 shares of the company’s stock valued at $151,000 after buying an additional 78 shares during the period. Finally, Tiemann Investment Advisors LLC purchased a new position in shares of McKesson Corporation during the first quarter valued at approximately $192,000. 89.04% of the stock is owned by hedge funds and other institutional investors.

McKesson Corporation (NYSE:MCK) traded down 2.68% during trading on Thursday, hitting $155.34. The stock had a trading volume of 2,339,282 shares. The firm has a market capitalization of $32.66 billion, a P/E ratio of 7.11 and a beta of 1.13. The stock has a 50 day moving average of $164.64 and a 200 day moving average of $151.68. McKesson Corporation has a one year low of $114.53 and a one year high of $197.08.

McKesson Corporation (NYSE:MCK) last released its quarterly earnings results on Thursday, July 27th. The company reported $2.46 EPS for the quarter, missing the consensus estimate of $2.81 by $0.35. The firm had revenue of $51.05 billion for the quarter, compared to the consensus estimate of $51.22 billion. McKesson Corporation had a return on equity of 25.76% and a net margin of 2.42%. The firm’s revenue was up 2.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $3.50 EPS. Equities research analysts expect that McKesson Corporation will post $12.11 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Monday, October 2nd. Stockholders of record on Friday, September 1st will be given a dividend of $0.34 per share. The ex-dividend date is Wednesday, August 30th. This represents a $1.36 annualized dividend and a dividend yield of 0.88%. This is a positive change from McKesson Corporation’s previous quarterly dividend of $0.28. McKesson Corporation’s dividend payout ratio is currently 5.00%.

TRADEMARK VIOLATION NOTICE: “Sentry Investments Corp. Increases Position in McKesson Corporation (NYSE:MCK)” was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this news story on another website, it was copied illegally and reposted in violation of United States and international trademark & copyright law. The original version of this news story can be read at https://www.thecerbatgem.com/2017/08/03/mckesson-corporation-nysemck-position-increased-by-sentry-investments-corp-updated-updated-updated.html.

Several brokerages recently commented on MCK. UBS AG reaffirmed a “neutral” rating and issued a $166.00 target price (up from $156.00) on shares of McKesson Corporation in a research report on Monday, June 26th. Vetr cut McKesson Corporation from a “strong-buy” rating to a “buy” rating and set a $187.51 target price for the company. in a research report on Monday, July 17th. Leerink Swann increased their price objective on McKesson Corporation to $170.00 and gave the stock a “market perform” rating in a research note on Thursday, June 29th. Barclays PLC set a $187.00 price objective on McKesson Corporation and gave the stock a “buy” rating in a research note on Sunday, June 4th. Finally, Zacks Investment Research upgraded McKesson Corporation from a “hold” rating to a “buy” rating and set a $184.00 price objective for the company in a research note on Wednesday, July 12th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and nine have issued a buy rating to the stock. McKesson Corporation currently has a consensus rating of “Hold” and a consensus price target of $171.21.

In related news, Director Marie L/Ca Knowles sold 1,083 shares of the company’s stock in a transaction dated Monday, July 31st. The shares were sold at an average price of $162.55, for a total value of $176,041.65. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Chairman John H. Hammergren sold 19,316 shares of the company’s stock in a transaction dated Tuesday, May 30th. The shares were sold at an average price of $162.31, for a total transaction of $3,135,179.96. Following the completion of the sale, the chairman now directly owns 96,644 shares of the company’s stock, valued at $15,686,287.64. The disclosure for this sale can be found here. Insiders have sold 60,231 shares of company stock valued at $9,830,297 in the last 90 days. Insiders own 1.20% of the company’s stock.

McKesson Corporation Company Profile

McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally.

Institutional Ownership by Quarter for McKesson Corporation (NYSE:MCK)

Receive News & Stock Ratings for McKesson Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson Corporation and related stocks with our FREE daily email newsletter.